These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6330355)

  • 1. Bicyclic lactam inhibitors of angiotensin converting enzyme.
    Watthey JW; Gavin T; Desai M
    J Med Chem; 1984 Jun; 27(6):816-8. PubMed ID: 6330355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme.
    Watthey JW; Stanton JL; Desai M; Babiarz JE; Finn BM
    J Med Chem; 1985 Oct; 28(10):1511-6. PubMed ID: 2995669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity.
    Hanessian S; Reinhold U; Saulnier M; Claridge S
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2123-8. PubMed ID: 9873498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New potent inhibitors of angiotensin converting enzyme.
    Attwood MR; Francis RJ; Hassall CH; Kröhn A; Lawton G; Natoff IL; Nixon JS; Redshaw S; Thomas WA
    FEBS Lett; 1984 Jan; 165(2):201-6. PubMed ID: 6319181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid.
    Reynolds CH
    Biochem Pharmacol; 1984 Apr; 33(8):1273-6. PubMed ID: 6324821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives.
    Stanton JL; Watthey JW; Desai MN; Finn BM; Babiarz JE; Tomaselli HC
    J Med Chem; 1985 Nov; 28(11):1603-6. PubMed ID: 2999394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of angiotensin I-converting enzyme in rat lung with captopril: the effect of adrenalectomy.
    Fyhrquist F; Grönhagen-Riska C; Forslund T; Tikkanen I
    Am J Cardiol; 1982 Apr; 49(6):1508-10. PubMed ID: 6280480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo.
    Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL
    Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents acting on the central nervous system. Synthesis of 3-phenyl-2-piperazinyl-1-benzazocines, 3-substituted-2-piperazinyl-1-benzazepines and related compounds.
    Hino K; Nagai Y; Uno H
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2386-400. PubMed ID: 3240466
    [No Abstract]   [Full Text] [Related]  

  • 10. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new bicyclic ring systems, 1,4,5-benzodioxazocine and 1,4-benzoxazepine.
    Luts HA
    J Pharm Sci; 1969 Dec; 58(12):1460-3. PubMed ID: 5353259
    [No Abstract]   [Full Text] [Related]  

  • 12. The design of a new group of angiotensin-converting enzyme inhibitors.
    Hassall CH; Kröhn A; Moody CJ; Thomas WA
    FEBS Lett; 1982 Oct; 147(2):175-9. PubMed ID: 6293868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
    Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Loots MJ; Perri MG; Petrillo EW; Powell JR
    J Med Chem; 1988 Jan; 31(1):204-12. PubMed ID: 3336020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal by acetylsalicylic acid of the captopril-induced inhibition of angiotensin converting enzyme in the hindquarters of guinea-pig.
    Melli M; Türker RK
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):87-93. PubMed ID: 6287951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors: accomplishments and challenges.
    Petrillo EW; Powell JR; Cushman DW; Ondetti MA
    Clin Exp Hypertens A; 1987; 9(2-3):235-41. PubMed ID: 3038385
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria.
    Nakashima A; Angus JA; Johnston CI
    Eur J Pharmacol; 1982 Jul; 81(3):487-92. PubMed ID: 6288415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and design of specific inhibitors of angiotensin-converting enzyme.
    Cushman DW; Cheung HS; Sabo EF; Ondetti MA
    Am J Cardiol; 1982 Apr; 49(6):1390-4. PubMed ID: 6176105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
    Krapcho J; Turk C; Cushman DW; Powell JR; DeForrest JM; Spitzmiller ER; Karanewsky DS; Duggan M; Rovnyak G; Schwartz J
    J Med Chem; 1988 Jun; 31(6):1148-60. PubMed ID: 2836590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.